Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

AIM: The aim of this study is to determine the incidence of T790M mutations after progression on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) and median duration on TKI before progression on TKI. METHODS: Records of Rajiv Gandhi Cancer Institute and Research Centre, of pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung India
Hauptverfasser: Babu Koyyala, Venkata Pradeep, Batra, Ullas, Jain, Parveen, Sharma, Mansi, Goyal, Pankaj, Medisetty, Pavani, Jajodia, Ankush, Maheshwari, Udip Dilip
Format: Artigo
Sprache:Inglês
Veröffentlicht: Medknow Publications & Media Pvt Ltd 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120311/
https://ncbi.nlm.nih.gov/pubmed/30168457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/lungindia.lungindia_451_17
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge